Genopathy
Gene-Disorder Association · Article
Gene
MIR27A
MicroRNA 27a
Manually curatedApproved treatment annotated
Association Review

In brief

The association between MIR27A (MicroRNA 27a) and Gastric Cancer is reported, supported by a single source.

Sources 1
Clinical variants 0
Symptoms 10
Compounds 2
Trials 384of 3,515 via MIR27A compounds
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
MIR27A

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Gastric Cancer

The disorder

31 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

2 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

3,515 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

7 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access